Clinical Trials Logo

Lung Cancer (Diagnosis) clinical trials

View clinical trials related to Lung Cancer (Diagnosis).

Filter by:
  • None
  • Page 1

NCT ID: NCT05110131 Active, not recruiting - Lung Cancer Clinical Trials

Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

This randomized crossover study aimed to evaluate whether a multimodal biopsy strategy using both needle and forceps can provide additive benefits compared with a single device for diagnosing peripheral pulmonary lesions with electromagnetic navigation bronchoscopy under moderate sedation and assess the comparative yield and discordance between the two devices.

NCT ID: NCT03830619 Completed - Clinical trials for Lung Cancer (Diagnosis)

Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis

Start date: January 1, 2017
Phase:
Study type: Observational

The study is to investigate the sensitivity and specificity of serum exosome noncoding RNA as a biomarker for the diagnosis of lung cancer

NCT ID: NCT03633006 Completed - Clinical trials for Lung Cancer (Diagnosis)

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer

Start date: April 11, 2016
Phase:
Study type: Observational

The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens for use in assessing new biomarkers for the detection of neoplasms of the lung. Subjects will be men and women, 35 years of age and older, with a CT confirmed nodule measuring 6-30 mm.

NCT ID: NCT03479099 Completed - Clinical trials for Circulating Tumor Cell

Liquid Biopsy in Lung Cancer

Start date: March 12, 2018
Phase:
Study type: Observational

The purpose of this study is to assess clinical utility of combined circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.